| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |